Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

AirPROM

Financiado

Cerrado

Airway Disease PRedicting Outcomes through Patient Specific Computational Modell...

Airway Disease PRedicting Outcomes through Patient Specific Computational Modelling The airways diseases asthma and chronic obstructive pulmonary disease affect over 400 million people world-wide and cause considerable morbidity and mortality. Airways disease costs the European Union in excess of €56 billion per... ver más

30/06/2016

ULEIC

16M€

Presupuesto del proyecto: 16M€

Líder del proyecto

UNIVERSITY OF LEICESTER No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 38 Participantes

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2016-06-30 No tenemos la información de la convocatoria

0% 75% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

38 Participantes

ULEIC

0.00€ | Lider

ANSYS

N.D. | Participante

Unife

N.D. | Participante

EUROPEAN LUNG FOUNDATION

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

RYC-2017-22532 Superordenadores y modelización computacional en cardiología 309K€ Cerrado

FIS2017-89535-C2-1-R MODELOS COMPUTACIONALES PERSONALIZADOS DE EPOC PARA LA FENOT... 73K€ Cerrado

P3AGI Public Private Partnership for Asthma Imaging and Genomics 1M€ Cerrado

BES-2016-078854 Computational Biology and Biomedical Systems 93K€ Cerrado

BES-2017-081164 Computational Biology and Biomedical Systems 93K€ Cerrado

PRE2018-084062 Computational biology and Biomedical Systems 93K€ Cerrado

Líder del proyecto

UNIVERSITY OF LEICESTER No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 16M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The airways diseases asthma and chronic obstructive pulmonary disease affect over 400 million people world-wide and cause considerable morbidity and mortality. Airways disease costs the European Union in excess of €56 billion per annum. Current therapies are inadequate and we do not have sufficient tools to predict disease progression or response to current or future therapies. Our consortium, Airway Disease PRedicting Outcomes through Patient Specific Computational Modelling (AirPROM), brings together the exisiting clinical consortia (EvA FP7, U-BIOPRED IMI and BTS Severe Asthma), and expertise in physiology, radiology, image analysis, bioengineering, data harmonization, data security and ethics, computational modeling and systems biology. We shall develop an integrated multi-scale model building upon existing models. This airway model will be comprised of an integrated 'micro-scale' and 'macro-scale' airway model informed and validated by 'omic data and ex vivo models at the genome-transcriptome-cell-tissue scale and by CT and functional MRI imaging coupled to detailed physiology at the tissue-organ scale utilising Europe's largest airway disease cohort. Validation will be undertaken cross-sectionally, following interventions and after longitudinal follow-up to incorporate both spatial and temporal dimensions. AirPROM has a comprehensive data management platform and a well-developed ethico-legal framework. Critically, AirPROM has an extensive exploitation plan, involving at its inception and throughout its evolution those that will 'develop' and 'use' the technologies emerging from this project. AirPROM therefore will bridge the critical gaps in our clinical management of airways disease, by providing validated models to predict disease progression and response to treatment and the platform to translate these patient-specific tools, so as to pave the way to improved, personalised management of airways disease.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores